Infectious Diseases Experts Panel to Discuss Future of Infectious Disease Therapeutics
Released on: January 23, 2008, 3:45 pm
Press Release Author: Four infectious diseases experts will discuss the future of infectious disease therapeutics at the 5th Anti-Infectives Partnering & Deal-Making Summit taking place on March 5-7, 2008 in Philadelphia, PA.
Industry: Pharmaceuticals
Press Release Summary: MONROVIA, CA - Four infectious diseases experts will discuss the future of infectious disease therapeutics at the 5th Anti-Infectives Partnering & Deal-Making Summit taking place on March 5-7, 2008 in Philadelphia, PA.
Press Release Body: MONROVIA, CA - Four infectious diseases experts will discuss the future of infectious disease therapeutics at the 5th Anti-Infectives Partnering & Deal-Making Summit taking place on March 5-7, 2008 in Philadelphia, PA.
Roger M. Echols, Chief Medical Officer for Replidyne, will moderate a forty-five minutes panel entitled, "Future of Infectious Disease Therapeutics". He will be joined by panelists Mike Fuller at Knobbe Martens Olson & Bear; Dennis Molnar, Vice President of Corporate Development for Paratek Pharmaceuticals; and Michael Dudley, Vice President of Drug Development for MPEX Pharmaceuticals.
Other topics to be covered at the 5th Anti-Infectives Partnering & Deal-Making Summit include New Anti-Infectives Technologies, Current Models of R&D Collaboration, New Pathogen Challenges, VC Investment Opportunities in the Anti-Infectives Space, and Developing Partnerships with Big Pharma.
Meet and hear presentations from experts of leading organizations such as AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Global Alliance for TB Drug Development, GlaxoSmithKline, Human Genome Sciences, Merck, Novartis, Wyeth, and many more. The full agenda is available online at www.gtcbio.com.
The 5th Anti-Infectives Partnering & Deal Making Summit is an infectious disease partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations, and learn about relevant anti-infective issues and deals that affect the industry.
This event also provides a unique venue for attendees to learn about the anti-infective business development trends, the infectious disease markets, and novel technologies that shape up the industry. For more information, please visit www.gtcbio.com.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
2012
